Wuhan Hege Biotechnology Co., Ltd.

首页登录页

About us

Wuhan Hege Biotechnology Co., Ltd. is jointly funded by China Regent and American AIDP. It was registered in Wuhan in 2004 and is a manufacturer with complex collagen (Collagen II) national invention patent technology and large-scale production capacity.
Chinese investor - China Regent
Founded in 1995, it is located in Hubei, China. It has been engaged in the research of bioengineering. It has a specialized and large-scale composite

Products

Compound Amino Acid Injection (3AA)

Oxaliplatin for Injection

Gemcitabine hydrochloride for injection (1.0g)

Gemcitabine hydrochloride for injection (0.2g)

News

On February 28, Yang Yunyan, vice governor of Hubei Province, inspected pharmaceutical for half a day

Abstract：

OnFebruary28,2020,YangYunyan,vicegovernorofHubeiProvince,accompaniedbyCuiYonghui,mayorofJingzhouCity,HuangZhen,vicemayorofJingzhouCityandSecretaryofJianliCountyPartycommittee,HanXu,YuanYuzhuo,ZhuShuandyouMang,leadersofJianliCounty,visitedHubeiBantianpharmaceuticalcompanytolearnmoreaboutthedevelopmentofenterpriseproductionandoperation,epidemicpreventionandcontrol,materialpreparation,etc. YangYunyanaffirmedtheepidemicpreventionandcontrolworkinJianliCounty.HestressedthatJianlishouldexportexternalpreventionandcontrol,continuetodoagoodjobinpreventionandcontrol,deeplypromotefineinvestigation,dofineflowregulation,controlthesourceofinfection,blocktherouteoftransmission,makeeveryefforttoimprovetheleveloftreatmentandconsolidatetheresultsofpreventionandcontrol.

In 2018, it won the title of "national advanced private enterprise in employment and social security"